西安(an)天美宣(xuan)布其(qi)截至2022年(nian)(nian)3月31日的(de)6個月的(de)半(ban)(ban)年(nian)(nian)度財(cai)務業績。2022財(cai)年(nian)(nian)上半(ban)(ban)年(nian)(nian)總收(shou)入(ru)為1370萬(wan)(wan)美元(yuan)(yuan)，比2021年(nian)(nian)同(tong)(tong)期(qi)的(de)1170萬(wan)(wan)美元(yuan)(yuan)增(zeng)(zeng)(zeng)長(chang)了(le)17.0%。凈利潤從(cong)2021年(nian)(nian)同(tong)(tong)期(qi)的(de)230萬(wan)(wan)美元(yuan)(yuan)增(zeng)(zeng)(zeng)加到250美元(yuan)(yuan)，增(zeng)(zeng)(zeng)長(chang)了(le)10.2%。香料原(yuan)料的(de)銷(xiao)售收(shou)入(ru)從(cong)2021年(nian)(nian)同(tong)(tong)期(qi)的(de)600萬(wan)(wan)美元(yuan)(yuan)增(zeng)(zeng)(zeng)加了(le)24.9%，達到740萬(wan)(wan)美元(yuan)(yuan)。膳食(shi)補充劑(固(gu)體(ti)飲料)產品(pin)的(de)銷(xiao)售收(shou)入(ru)從(cong)2021年(nian)(nian)同(tong)(tong)期(qi)的(de)470萬(wan)(wan)美元(yuan)(yuan)下(xia)降(jiang)到330萬(wan)(wan)美元(yuan)(yuan)，下(xia)降(jiang)了(le)28.5%。生物(wu)活性食(shi)品(pin)原(yuan)料產品(pin)的(de)銷(xiao)售收(shou)入(ru)從(cong)2021年(nian)(nian)同(tong)(tong)期(qi)的(de)110萬(wan)(wan)美元(yuan)(yuan)增(zeng)(zeng)(zeng)加到290萬(wan)(wan)美元(yuan)(yuan)，增(zeng)(zeng)(zeng)加了(le)171.8%。(醫藥健聞)